Whither interferon for myeloma and other hematologic malignancies?

被引:5
作者
Alexanian, R
Weber, D
机构
关键词
D O I
10.7326/0003-4819-124-2-199601150-00012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:264 / 265
页数:2
相关论文
共 16 条
  • [1] ALEXANIAN R, 1994, NEW ENGL J MED, V330, P484
  • [2] RANDOMIZED TRIAL OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP
    BROWMAN, GP
    BERGSAGEL, D
    SICHERI, D
    OREILLY, S
    WILSON, KS
    RUBIN, S
    BELCH, A
    SHUSTIK, C
    BARR, R
    WALKER, I
    JAMES, K
    ZEE, B
    JOHNSTON, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2354 - 2360
  • [3] A RANDOMIZED CLINICAL-TRIAL COMPARING MELPHALAN PREDNISONE WITH OR WITHOUT INTERFERON ALFA-2B IN NEWLY DIAGNOSED PATIENTS WITH MULTIPLE-MYELOMA - A CANCER AND LEUKEMIA GROUP-B STUDY
    COOPER, MR
    DEAR, K
    MCINTYRE, OR
    OZER, H
    ELLERTON, J
    CANELLOS, G
    BERNHARDT, B
    DUGGAN, D
    FARAGHER, D
    SCHIFFER, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (01) : 155 - 160
  • [4] CUNNINGHAM D, 1993, P AN M AM SOC CLIN, V12, P364
  • [5] Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma - A randomized, controlled trial
    Hjorth, M
    Westin, J
    Dahl, IMS
    Gimsing, P
    Hippe, E
    Holmberg, E
    Lamvik, J
    Nielsen, JL
    Lofvenberg, E
    Palva, IP
    Rodjer, S
    Talstad, I
    Turesson, I
    Wisloff, F
    Zador, G
    AmslerNordin, S
    Polgary, M
    Oden, A
    Wallgren, A
    Wilhelmsen, L
    Hellqvist, L
    Hasselblom, S
    Carneskog, J
    Lindqvist, O
    Hoffman, P
    Olsson, K
    Tholen, A
    Stolt, CM
    Rindner, A
    Svensson, R
    Vaart, J
    Hansen, S
    Engqvist, L
    Lannemyr, O
    Nilsson, PG
    Linne, I
    Lilja, G
    Tallroth, G
    Hallgren, J
    Andersson, B
    Billstrom, R
    Persson, S
    Samuelsson, T
    Odeberg, H
    Adriansson, M
    Tove, H
    Stobeus, N
    Habberstad, J
    End, T
    Dahlen, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 124 (02) : 212 - +
  • [6] INTERFERON-ALPHA FOR INDUCTION AND MAINTENANCE IN MULTIPLE-MYELOMA - RESULTS OF 2 MULTICENTER RANDOMIZED TRIALS AND SUMMARY OF OTHER STUDIES
    LUDWIG, H
    COHEN, AM
    POLLIACK, A
    HUBER, H
    NACHBAUR, D
    SENN, HJ
    MORANT, R
    ECKHARDT, S
    GUNCZLER, P
    SEEWANN, HL
    SCHULLER, J
    RHYNER, K
    CAVALLI, F
    FRITZ, E
    [J]. ANNALS OF ONCOLOGY, 1995, 6 (05) : 467 - 476
  • [7] MAINTENANCE TREATMENT WITH RECOMBINANT INTERFERON ALFA-2B IN PATIENTS WITH MULTIPLE-MYELOMA RESPONDING TO CONVENTIONAL INDUCTION CHEMOTHERAPY
    MANDELLI, F
    AVVISATI, G
    AMADORI, S
    BOCCADORO, M
    GERNONE, A
    LAUTA, VM
    MARMONT, F
    PETRUCCI, MT
    TRIBALTO, M
    VEGNA, ML
    DAMMACCO, F
    PILERI, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (20) : 1430 - 1434
  • [8] CHOP-BLEO PLUS INTERFERON FOR STAGE-IV LOW-GRADE LYMPHOMA
    MCLAUGHLIN, P
    CABANILLAS, F
    HAGEMEISTER, FB
    SWAN, F
    ROMAGUERA, JE
    TAYLOR, S
    RODRIGUEZ, MA
    VELASQUEZ, WS
    REDMAN, JR
    GUTTERMAN, JU
    [J]. ANNALS OF ONCOLOGY, 1993, 4 (03) : 205 - 211
  • [9] MELLSTEDT H, 1979, LANCET, V1, P245
  • [10] INTERFERON MAINTENANCE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA IN REMISSION AFTER FLUDARABINE THERAPY
    OBRIEN, S
    KANTARJIAN, H
    BERAN, M
    ROBERTSON, LE
    KOLLER, C
    LERNER, S
    KEATING, MJ
    [J]. BLOOD, 1995, 86 (04) : 1296 - 1300